Compagnie Lombard Odier S Cm A Centessa Pharmaceuticals PLC Transaction History

Compagnie Lombard Odier S Cm A

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$6.73 - $12.2 $39,168 - $71,004	-5,820 Closed	0 $0
Q3 2022 Nov 09, 2022	BUY	$3.8 - $5.91 $22,116 - $34,396	5,820 New	5,820 $23,000
Q1 2022 Apr 27, 2022	SELL	$7.45 - $11.59 $43,359 - $67,453	-5,820 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$10.99 - $17.54 $33,739 - $53,847	3,070 Added 111.64%	5,820 $66,000
Q3 2021 Oct 28, 2021	BUY	$16.7 - $23.11 $45,925 - $63,552	2,750 New	2,750 $46,000

106

118M

5.9K

53K

Ticker CNTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,339,296
Market Cap $1.6B
Description
Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.